LMR Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.9M Buy
+43,644
New +$22.9M 0.16% 69
2024
Q4
Sell
-229
Closed -$241K 994
2024
Q3
$241K Buy
+229
New +$241K ﹤0.01% 485
2024
Q2
Sell
-197
Closed -$190K 921
2024
Q1
$190K Buy
197
+28
+17% +$27K ﹤0.01% 463
2023
Q4
$148K Sell
169
-327
-66% -$287K ﹤0.01% 432
2023
Q3
$408K Sell
496
-317
-39% -$261K ﹤0.01% 390
2023
Q2
$584K Buy
+813
New +$584K 0.01% 366
2023
Q1
Sell
-9,766
Closed -$7.05M 1141
2022
Q4
$7.05M Buy
+9,766
New +$7.05M 0.12% 196
2022
Q3
Sell
-2,573
Closed -$1.52M 1280
2022
Q2
$1.52M Buy
2,573
+2,111
+457% +$1.25M 0.03% 601
2022
Q1
$323K Buy
+462
New +$323K ﹤0.01% 1057
2021
Q4
Sell
-2,637
Closed -$1.6M 1243
2021
Q3
$1.6M Buy
2,637
+1,757
+200% +$1.06M 0.02% 503
2021
Q2
$492K Buy
+880
New +$492K 0.01% 669
2021
Q1
Sell
-1,625
Closed -$785K 1045
2020
Q4
$785K Buy
+1,625
New +$785K 0.01% 307
2020
Q3
Sell
-17,276
Closed -$10.8M 598
2020
Q2
$10.8M Buy
17,276
+15,759
+1,039% +$9.83M 0.27% 62
2020
Q1
$718K Sell
1,517
-789
-34% -$373K 0.03% 150
2019
Q4
$866 Sell
2,306
-1,449
-39% -$544 ﹤0.01% 232
2019
Q3
$1.04M Buy
+3,755
New +$1.04M 0.05% 164
2018
Q2
Sell
-1,405
Closed -$528K 567
2018
Q1
$528K Hold
1,405
0.05% 247
2017
Q4
$528K Buy
1,405
+618
+79% +$232K 0.05% 247
2017
Q3
$352K Sell
787
-3,003
-79% -$1.34M 0.04% 224
2017
Q2
$1.86M Sell
3,790
-1,219
-24% -$599K 0.12% 182
2017
Q1
$1.94M Buy
+5,009
New +$1.94M 0.19% 85
2016
Q3
Sell
-1,549
Closed -$541K 455
2016
Q2
$541K Buy
1,549
+698
+82% +$244K 0.08% 274
2016
Q1
$307 Sell
851
-771
-48% -$278 0.03% 322
2015
Q4
$881K Buy
1,622
+624
+63% +$339K 0.29% 73
2015
Q3
$464K Sell
998
-7,205
-88% -$3.35M 0.05% 226
2015
Q2
$4.18M Buy
8,203
+4,457
+119% +$2.27M 0.51% 30
2015
Q1
$1.69M Buy
3,746
+808
+28% +$365K 0.23% 118
2014
Q4
$1.21M Sell
2,938
-43,116
-94% -$17.7M 0.16% 181
2014
Q3
$16.6M Buy
+46,054
New +$16.6M 1.32% 25